193 related articles for article (PubMed ID: 32717794)
1. Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology.
Urbina F; Morales-Pison S; Maldonado E
Polymers (Basel); 2020 Jul; 12(8):. PubMed ID: 32717794
[TBL] [Abstract][Full Text] [Related]
2. RNA polymerase II components and Rrn7 form a preinitiation complex on the HomolD box to promote ribosomal protein gene expression in Schizosaccharomyces pombe.
Montes M; Moreira-Ramos S; Rojas DA; Urbina F; Käufer NF; Maldonado E
FEBS J; 2017 Feb; 284(4):615-633. PubMed ID: 28060464
[TBL] [Abstract][Full Text] [Related]
3. Chemical Modifications of mRNA Ends for Therapeutic Applications.
Warminski M; Mamot A; Depaix A; Kowalska J; Jemielity J
Acc Chem Res; 2023 Oct; 56(20):2814-2826. PubMed ID: 37782471
[TBL] [Abstract][Full Text] [Related]
4. The mRNA cap-binding protein Cbc1 is required for high and timely expression of genes by promoting the accumulation of gene-specific activators at promoters.
Li T; De Clercq N; Medina DA; Garre E; Sunnerhagen P; Pérez-Ortín JE; Alepuz P
Biochim Biophys Acta; 2016 Feb; 1859(2):405-19. PubMed ID: 26775127
[TBL] [Abstract][Full Text] [Related]
5. A history of poly A sequences: from formation to factors to function.
Edmonds M
Prog Nucleic Acid Res Mol Biol; 2002; 71():285-389. PubMed ID: 12102557
[TBL] [Abstract][Full Text] [Related]
6. Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.
Gilinger G; Bellofatto V
Nucleic Acids Res; 2001 Apr; 29(7):1556-64. PubMed ID: 11266558
[TBL] [Abstract][Full Text] [Related]
7. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner.
Perlow RA; Kolbanovskii A; Hingerty BE; Geacintov NE; Broyde S; Scicchitano DA
J Mol Biol; 2002 Aug; 321(1):29-47. PubMed ID: 12139931
[TBL] [Abstract][Full Text] [Related]
8. Characterization and regulation of two testicular inhibin/activin beta B-subunit messenger ribonucleic acids that are transcribed from alternate initiation sites.
Feng ZM; Wu AZ; Chen CL
Endocrinology; 1995 Mar; 136(3):947-55. PubMed ID: 7867604
[TBL] [Abstract][Full Text] [Related]
9. Insight into Influenza: A Virus Cap-Snatching.
De Vlugt C; Sikora D; Pelchat M
Viruses; 2018 Nov; 10(11):. PubMed ID: 30453478
[TBL] [Abstract][Full Text] [Related]
10. Evolution of viral DNA-dependent RNA polymerases.
Sonntag KC; Darai G
Virus Genes; 1995; 11(2-3):271-84. PubMed ID: 8828152
[TBL] [Abstract][Full Text] [Related]
11. Transcription directionality is licensed by Integrator at active human promoters.
Yang J; Li J; Miao L; Gao X; Sun W; Linghu S; Ren G; Peng B; Chen S; Liu Z; Wang B; Dong A; Huang D; Yuan J; Dang Y; Lai F
Nat Struct Mol Biol; 2024 Apr; ():. PubMed ID: 38649617
[TBL] [Abstract][Full Text] [Related]
12. The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers.
Shigekane H; Kawaguchi Y; Shirakata M; Sakaguchi M; Hirai K
Arch Virol; 1999; 144(10):1893-907. PubMed ID: 10550664
[TBL] [Abstract][Full Text] [Related]
13. RNA primers and the role of host nuclear RNA polymerase II in influenza viral RNA transcription.
Krug RM; Bouloy M; Plotch SJ
Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):359-70. PubMed ID: 6103553
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the polyoma virus early and late promoters by transcription in vitro.
Jat P; Roberts JW; Cowie A; Kamen R
Nucleic Acids Res; 1982 Feb; 10(3):871-87. PubMed ID: 6174941
[TBL] [Abstract][Full Text] [Related]
15. Making ends meet: coordination between RNA 3'-end processing and transcription initiation.
Andersen PK; Jensen TH; Lykke-Andersen S
Wiley Interdiscip Rev RNA; 2013; 4(3):233-46. PubMed ID: 23450686
[TBL] [Abstract][Full Text] [Related]
16. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
[TBL] [Abstract][Full Text] [Related]
17. Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization.
Kore AR; Shanmugasundaram M; Charles I; Vlassov AV; Barta TJ
J Am Chem Soc; 2009 May; 131(18):6364-5. PubMed ID: 19385620
[TBL] [Abstract][Full Text] [Related]
18. Transcription activation by catabolite activator protein (CAP).
Busby S; Ebright RH
J Mol Biol; 1999 Oct; 293(2):199-213. PubMed ID: 10550204
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the Escherichia coli bgl promoter: effects of template supercoiling and cell extracts on promoter activity in vitro.
Schnetz K; Wang JC
Nucleic Acids Res; 1996 Jun; 24(12):2422-8. PubMed ID: 8710516
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the activating region of Escherichia coli catabolite gene activator protein (CAP). II. Role at Class I and class II CAP-dependent promoters.
Zhou Y; Merkel TJ; Ebright RH
J Mol Biol; 1994 Nov; 243(4):603-10. PubMed ID: 7966285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
